Modified Desaturation Distance Ratio (mDDR) predicts prognosis in patients with Pulmonary Arterial Hypertension.

X. Alsina (Cubelles, Spain)

Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Session: Exercise and physiology in pulmonary hypertension
Session type: Thematic Poster
Number: 2390
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
X. Alsina (Cubelles, Spain). Modified Desaturation Distance Ratio (mDDR) predicts prognosis in patients with Pulmonary Arterial Hypertension.. 2390

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Improvement of hypoxemia in patients affected by Pulmonary Arterial Hypertension (PAH) after a session of Controlled Breathing (CB)
Source: International Congress 2019 – Novel interventions and models of pulmonary rehabilitation
Year: 2019

Effects on Right Ventricular size and function by Riociguat in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (The RIVER Study)
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018

Electrocardiographic abnormalities in patients with low or moderate risk pulmonary embolism: Prevalence and association with PO2 /FiO2 ratio
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Incidence of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) at six months of a Pulmonary Embolism (PE). OSIRIS Study
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017

Usefulness of NT-proBNP dosage during the follow-up of PAH: Comparison with 6MWD
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014


Risk assessment in Pulmonary Arterial Hypertension (PAH) based on the Simplified French Model: A single centre experience
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021


Prognostic value of outcome variables at follow-up in patients with PAH
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014

A Minimal Clinically Important Difference for CAMPHOR in Idiopathic Pulmonary Arterial Hypertension
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020


Red Blood Cell Distribution Width as a potential predictor of Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


Relevance of echocardiographic composite index to improve the detection of pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Evaluation of a novel clinic for management of Chronic Thromboembolic Pulmonary Disease (CTED) and associated Pulmonary Hypertension (CTEPH).
Source: International Congress 2017 – PAH and CTEPH
Year: 2017

Sleep Disordered Breathing (SDB) and Chronic Thromboembolic Pulmonary Hypertension: the Effects of Pulmonary Endoarterectomy
Source: International Congress 2017 – CPAP therapy
Year: 2017


Is serum cystatin C a predictor of acute pulmonary thromboembolism in patients with normal renal function?
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Assessment of lung function in symptomatic and asymptomatic smokers without Chronic Obstructive Pulmonary Disease (COPD) using the Impulse Oscillatory Technique (IOT)
Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Year: 2020


Would RDW be a prognostic factor in pulmonary arterial hypertension?
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018

Endothelial dysfunction in pulmonary embolism: Neutrophil-lymphocyte and platelet-lymphocyte ratio
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


PP219 – Development and Validation of a Novel Prognostic Nomogram for COPD patients with Pulmonary Hypertension
Source: ERS Lung Science Conference 2021
Year: 2021

Serum apelin 13 levels in patients with pulmonary embolism
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Exercise-induced pulmonary pressure changes in scleroderma patients – A follow-up study
Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange
Year: 2014